MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Cytokinetics, Incorporated Shares 2011-2026 | CYTK
Annual Shares Cytokinetics, Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 K | 112 K | 96.5 K | 89.8 K | 76.9 K | 64.5 K | 57.6 M | 54.4 M | 49.4 M | 39.9 M | 38.8 M | 35.7 M | 27.3 M | 18.1 M | 11.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 57.6 M | 64.5 K | 22.2 M |
Quarterly Shares Cytokinetics, Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 K | 119 K | 118 K | 118 K | 109 K | 102 K | 96.1 K | 95.8 K | 95.2 K | - | 93.8 K | 85.7 K | 85 K | 84.8 M | 80.3 K | 71.8 K | 71.2 K | 71 M | 68.3 K | 59.6 K | 59.3 K | 59.2 M | 58.6 K | 57.6 K | 54.8 K | 54.7 M | 54.6 M | 54.3 M | 54.1 M | 54 M | 53.7 M | 48.2 M | 41.6 M | 40.6 M | 39.9 M | 39.7 M | 39.6 M | 39.6 M | 38.8 M | 38.7 M | 38.7 M | 38.7 M | 36.6 M | 36.4 M | 33 M | 30.7 M | 29.4 M | 25.8 M | 24 M | 23.7 M | 22.4 M | 13.5 M | 76.1 M | 74.9 M | 72.3 M | 71.2 M | 74.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 84.8 M | 54.8 K | 29.1 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aptorum Group Limited
APM
|
7.35 M | $ 0.87 | -0.11 % | $ 6.4 M |  China |
 |
Aquestive Therapeutics
AQST
|
107 M | $ 4.18 | 1.95 % | $ 447 M |  USA |
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
64.7 M | $ 9.76 | 1.77 % | $ 631 M | USA |
 |
AgeX Therapeutics
AGE
|
10.2 M | - | -10.17 % | $ 12.2 K | USA |
 |
BioNTech SE
BNTX
|
244 M | $ 96.92 | -6.31 % | $ 27.2 B | Germany |
 |
I-Mab
IMAB
|
220 M | - | - | $ 866 M | China |
 |
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | USA |
 |
Burford Capital Limited
BUR
|
219 M | $ 5.12 | 3.96 % | $ 799 M |  Britain |
 |
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | Britain |
 |
AlloVir
ALVR
|
15.3 M | - | 4.14 % | $ 49.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B | France |
 |
ACADIA Pharmaceuticals
ACAD
|
166 M | $ 21.99 | -2.05 % | $ 3.64 B | USA |
 |
Cerus Corporation
CERS
|
191 M | $ 2.89 | 42.45 % | $ 551 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
4.28 M | - | - | $ 269 M | USA |
 |
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M |  Israel |
 |
AstraZeneca PLC
AZN
|
1.42 B | - | - | $ 96.9 B | Britain |
 |
Atreca
BCEL
|
38.6 M | - | -11.76 % | $ 5.79 M | USA |
 |
Berkeley Lights
BLI
|
68.9 M | - | -7.31 % | $ 87 M | USA |
 |
Calithera Biosciences
CALA
|
73.9 M | - | -10.95 % | $ 876 K | USA |
 |
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
CymaBay Therapeutics
CBAY
|
106 M | - | - | $ 3.45 B | USA |
 |
ChemoCentryx
CCXI
|
69.9 K | - | - | $ 3.74 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
Caladrius Biosciences
CLBS
|
8.33 M | - | -16.75 % | $ 25.8 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
21.6 M | - | - | $ 231 M | USA |
 |
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M |  Canada |
 |
Brainstorm Cell Therapeutics
BCLI
|
9.27 M | - | -2.5 % | $ 5.88 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
85.1 M | - | - | $ 2.18 B | USA |
 |
AIkido Pharma
AIKI
|
14.3 M | - | 1.93 % | $ 17.4 M | USA |
 |
Innate Pharma S.A.
IPHA
|
79.5 M | $ 1.44 | - | $ 235 M | France |
 |
Dynavax Technologies Corporation
DVAX
|
130 M | - | - | $ 2.02 B | USA |
 |
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
86.8 M | - | - | $ 28.6 M | USA |
 |
Editas Medicine
EDIT
|
88.7 M | $ 2.88 | -4.17 % | $ 256 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.65 M | $ 2.97 | -6.9 % | $ 4.89 M | Israel |
 |
Edesa Biotech
EDSA
|
3.2 M | $ 18.1 | -0.96 % | $ 57.9 M | USA |
 |
Eiger BioPharmaceuticals
EIGR
|
1.48 M | - | -9.21 % | $ 2.55 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
2.17 M | - | -5.68 % | $ 8.28 M | USA |
 |
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | Germany |
 |
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | USA |
 |
Applied Therapeutics
APLT
|
84.2 M | - | - | $ 8.42 M | USA |
 |
Evogene Ltd.
EVGN
|
40.4 M | $ 0.8 | 2.56 % | $ 27.9 M | Israel |
 |
Aptose Biosciences
APTO
|
2.45 M | - | -45.71 % | $ 1.2 M | Canada |